RECRUITINGINTERVENTIONAL
Comparison of Outcomes With Multifocal Intraocular Lenses
About This Trial
The purpose of this study is to compare and evaluate the clinical outcomes of 6 kinds of Multifocal Intraocular Lenses: SN6AD1, SBL-3, LS-313 MF30, AT LISA tri 839 MP, ART, LS-313 MF30T.
Who May Be Eligible (Plain English)
Who May Qualify:
- Age from 40 to 80 years old, either gender;
- Patients with bilateral age related cataracts, require bilateral cataract phacoemulsification combined Intraocular Lens implantation;
- Willing to undergo second eye surgery within 7 days after first eye surgery;
- The potential postoperative visual acuity of 20/40 or better in both eyes;
- Preoperative measurement of corneal astigmatism indicate the subjects are suitable for multifocal intraocular lenses implantation;
- Capability to understand the willing to sign a consent form and willing and able to attend study
Who Should NOT Join This Trial:
- Preexisting ocular diseases or conditions other than age related cataracts, have contraindications for cataract surgery;
- Preexisting systemic diseases or conditions that may confound the results of the study;
- Previous ocular surgery history or ocular trauma that may confound the results of the study;
- Require combined surgery that may confound the results of the study;
- Previous participation in other clinical trial within 30 days of this study start;
- Systemic or ocular medications that may confound the outcome of the intervention
- Pregnant, lactating, or planning to become pregnant during the course of the trial;
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Age from 40 to 80 years old, either gender;
* Patients with bilateral age related cataracts, require bilateral cataract phacoemulsification combined Intraocular Lens implantation;
* Willing to undergo second eye surgery within 7 days after first eye surgery;
* The potential postoperative visual acuity of 20/40 or better in both eyes;
* Preoperative measurement of corneal astigmatism indicate the subjects are suitable for multifocal intraocular lenses implantation;
* Capability to understand the informed consent and willing and able to attend study
Exclusion Criteria:
* Preexisting ocular diseases or conditions other than age related cataracts, have contraindications for cataract surgery;
* Preexisting systemic diseases or conditions that may confound the results of the study;
* Previous ocular surgery history or ocular trauma that may confound the results of the study;
* Require combined surgery that may confound the results of the study;
* Previous participation in other clinical trial within 30 days of this study start;
* Systemic or ocular medications that may confound the outcome of the intervention
* Pregnant, lactating, or planning to become pregnant during the course of the trial;
Treatments Being Tested
DEVICE
SN6AD1
Bilateral cataract surgery with implantation of SN6AD1 multifocal IOLs
DEVICE
SBL-3
Bilateral cataract surgery with implantation of SBL-3 multifocal IOLs
DEVICE
LS-313 MF30
Bilateral cataract surgery with implantation of LS-313 MF30 multifocal IOLs
DEVICE
AT LISA tri 839 MP
Bilateral cataract surgery with implantation of AT LISA tri 839 MP multifocal IOLs
DEVICE
ART
Bilateral cataract surgery with implantation of ART toric multifocal IOLs
DEVICE
LS-313 MF30T
Bilateral cataract surgery with implantation of LS-313 MF30T toric multifocal IOLs
Locations (1)
The Eye Hispital of Wenzhou Medical University
Wenzhou, Zhejiang, China